American Century Companies’s Vigil Neuroscience VIGL Stock Holding History

American Century Companies's VIGL Position: Q3 2025 in Review

American Century Companies sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 22,879 shares — an estimated $182K sold.

American Century Companies first reported a position in VIGL in Q3 2024 and held it in 4 quarters. The position peaked at $182K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

• American Century Companies reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
• American Century Companies sold 22,879 Vigil Neuroscience shares in Q3 2025, an estimated $182K.
• American Century Companies first reported a position in Vigil Neuroscience in Q3 2024 and held it in 4 quarters.
• American Century Companies's Vigil Neuroscience position peaked at $182K in Q2 2025.
• 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.